Abstract
Papillary adenocarcinomas of the stomach are rare and associated with a high rate of lymphovascular invasion and distant metastasis. However, the association between papillary adenocarcinoma and bone metastasis in gastric cancer remains largely unexplored. We report a rare case of bone metastasis as a recurrence of early papillary adenocarcinoma of the stomach after curative surgery. A 75-year-old man with a pedunculated polyp at the pylorus of the stomach was diagnosed with papillary adenocarcinoma after biopsy of the lesion, and the polyp was surgically resected. Pathohistological examination revealed intramucosal cancer without lymphovascular invasion or lymph node metastasis. Eight months after surgery, imaging studies showed osteolysis in the right sacrum, and the lesion was diagnosed as a bone metastasis after biopsy. The patient received palliative chemotherapy and radiotherapy for the bone metastasis, which resulted in relief of his leg pain. Subsequently, he was provided supportive care when his condition deteriorated, and he died 8 months after the diagnosis of bone metastasis. Our case shows that bone metastasis should not be overlooked, even though it is rare in gastric cancer patients. Papillary adenocarcinoma of the stomach should be carefully followed up through imaging examinations, even after curative resection.
Similar content being viewed by others
References
Gotoda T, Jung H-Y. Endoscopic resection (endoscopic mucosal resection/endoscopic submucosal dissection) for early gastric cancer. Dig Endosc. 2013;25(Suppl 1):55–63.
Lai JF, Kim S, Kim K, et al. Prediction of recurrence of early gastric cancer after curative resection. Ann Surg Oncol. 2009;16:1896–902.
Youn HG, An JY, Choi MG, et al. Recurrence after curative resection of early gastric cancer. Ann Surg Oncol. 2010;17:448–54.
Suzuki H, Oda I, Abe S, et al. High rate of 5-year survival among patients with early gastric cancer undergoing curative endoscopic submucosal dissection. Gastric Cancer. 2016;19:198–205.
Sun W, Han X, Wu S, et al. Endoscopic resection versus surgical resection for early gastric cancer. Medicine (Baltimore). 2015;94:e1649.
Choi HJ, Kim SM, An JY, et al. Risk factors and tumor recurrence in pT1N0M0 gastric cancer after surgical treatment. J Gastric Cancer. 2016;16:215–20.
Yasuda K, Adachi Y, Shiraishi N, et al. Papillary adenocarcinoma of the stomach. Gastric Cancer. 2000;3:33–8.
Yu H, Fang C, Chen L, et al. Worse prognosis in papillary, compared to tubular early gastric carcinoma. J Cancer. 2017;8:117–23.
Fujita T, Gotohda N, Kato Y, et al. Clinicopathological features of stomach cancer with invasive micropapillary component. Gastric Cancer. 2012;15:179–87.
Nakashima Y, Yao T, Hirahashi M, et al. Nuclear atypia grading score is a useful prognostic factor in papillary gastric adenocarcinoma. Histopathology. 2011;59:841–9.
Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer. 2002;2:584–93.
Park JM, Song KY, Kim WC, et al. Bone recurrence after curative resection of gastric cancer. Gastric Cancer. 2013;16:362–9.
Kobayashi M, Okabayashi T, Sano T, et al. Metastatic bone cancer as a recurrence of early gastric cancer––characteristics and possible mechanisms. World J Gastroenterol. 2005;11:5587–91.
Koseki K, Takizawa T, Koike M, et al. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer. 2000;89:724–32.
Nakamura T, Yao T, Kabashima A, et al. Loss of phenotypic expression is related to tumour progression in early gastric differentiated adenocarcinoma. Histopathology. 2005;47:357–67.
Kelly PJ, Peterson LFA, Pease DC, Zamboni L. Circulation of Bone. In: Abramson DI, editor. Blood vessels and lymphatics. 1st ed. New York: Academic Press; 1962. p. 531–556.
Takeuchi H, Kitagawa Y. Circulating tumor cells in gastrointestinal cancer. J Hepatobiliary Pancreat Sci. 2010;17:577–82.
Shimazu K, Fukuda K, Yoshida T, et al. High circulating tumor cell concentrations in a specific subtype of gastric cancer with diffuse bone metastasis at diagnosis. World J Gastroenterol. 2016;22:6083–8.
De Felice F, Piccioli A, Musio D, et al. The role of radiation therapy in bone metastases management. Oncotarget. 2017;8:25691–9.
Body J-J. Denosumab for the management of bone disease in patients with solid tumors. Expert Rev Anticancer Ther. 2012;12:307–22.
Silvestris N, Pantano F, Ibrahim T, et al. Natural history of malignant bone disease in gastric cancer: final results of a multicenter bone metastasis survey. PLoS ONE. 2013;8:e74402.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Nobukazu Agatsuma, Yoshitaka Nishikawa, Takahiro Horimatsu, Yasuki Nakatani, Noriko Juri, Takuji Akamatsu, Takeshi Seta, Sachiko Minamiguchi and Yukitaka Yamashita declare that they have no conflict of interest.
Human rights
All the procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Informed consent
Informed consent was obtained from all patients for being included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Agatsuma, N., Nishikawa, Y., Horimatsu, T. et al. Bone metastasis as a recurrence of early papillary adenocarcinoma of the stomach. Clin J Gastroenterol 13, 349–353 (2020). https://doi.org/10.1007/s12328-019-01050-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12328-019-01050-1